Annual Operating Margin
-228.99%
+366.52%+61.55%
31 December 2023
Summary:
Adaptimmune Therapeutics annual operating profit margin is currently -228.99%, with the most recent change of +366.52% (+61.55%) on 31 December 2023. During the last 3 years, it has risen by +3141.53% (+93.21%). ADAP annual operating margin is now -1797.48% below its all-time high of 13.49%, reached on 01 December 2013.ADAP Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-35.89%
-89.47%-166.98%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly operating profit margin is currently -35.89%, with the most recent change of -89.47% (-166.98%) on 30 September 2024. Over the past year, it has increased by +601.26% (+94.37%). ADAP quarterly operating margin is now -166.98% below its all-time high of 53.58%, reached on 30 June 2024.ADAP Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.5% | +94.4% |
| 3 y3 years | +93.2% | +99.0% |
| 5 y5 years | -65.4% | +99.8% |
ADAP Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +93.2% | -167.0% | +99.8% |
| 5 y | 5 years | -65.4% | +98.2% | -167.0% | +99.8% |
| alltime | all time | -1797.5% | +98.2% | -167.0% | +99.8% |
Adaptimmune Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -35.89%(-167.0%) |
| June 2024 | - | 53.58%(-106.2%) |
| Mar 2024 | - | -867.58%(-96.0%) |
| Dec 2023 | -228.99%(-61.5%) | -21.58 K%(+3287.4%) |
| Sept 2023 | - | -637.15%(-27.2%) |
| June 2023 | - | -875.40%(<-9900.0%) |
| Mar 2023 | - | 7.06%(-103.1%) |
| Dec 2022 | -595.51%(-77.4%) | -226.20%(-63.1%) |
| Sept 2022 | - | -613.53%(-22.3%) |
| June 2022 | - | -790.03%(-43.5%) |
| Mar 2022 | - | -1398.07%(-53.8%) |
| Dec 2021 | -2638.58%(-21.7%) | -3024.98%(-13.7%) |
| Sept 2021 | - | -3506.32%(+176.0%) |
| June 2021 | - | -1270.18%(-85.5%) |
| Mar 2021 | - | -8730.18%(+249.6%) |
| Dec 2020 | -3370.52%(-72.9%) | -2497.54%(-16.9%) |
| Sept 2020 | - | -3007.12%(-50.1%) |
| June 2020 | - | -6026.49%(+54.1%) |
| Mar 2020 | - | -3911.17%(-6.2%) |
| Dec 2019 | -12.46 K% | -4169.64%(-75.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -16.93 K%(-25.1%) |
| June 2019 | - | -22.61 K%(+941.7%) |
| Dec 2018 | -138.42%(-35.1%) | -2170.79%(<-9900.0%) |
| Sept 2018 | - | 17.20%(-105.4%) |
| June 2018 | - | -319.51%(-8.9%) |
| Mar 2018 | - | -350.66%(-49.6%) |
| Dec 2017 | -213.20%(-58.4%) | -695.55%(+3711.2%) |
| Sept 2017 | - | -18.25%(-97.3%) |
| June 2017 | - | -675.38%(-13.2%) |
| Mar 2017 | - | -777.77%(+353.0%) |
| Dec 2016 | -512.74%(+74.3%) | -171.70%(-77.7%) |
| Sept 2016 | - | -770.61%(-88.9%) |
| June 2016 | - | -6920.73%(+1100.3%) |
| Mar 2016 | - | -576.59%(+120.7%) |
| Dec 2015 | -294.13%(+17.8%) | - |
| Sept 2015 | - | -261.31%(+46.9%) |
| June 2015 | -249.63%(-82.1%) | - |
| Dec 2014 | - | -177.85%(-31.7%) |
| Sept 2014 | - | -260.38% |
| June 2014 | -1396.48%(<-9900.0%) | - |
| Dec 2013 | 13.49% | - |
FAQ
- What is Adaptimmune Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual operating margin year-on-year change?
- What is Adaptimmune Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly operating margin year-on-year change?
What is Adaptimmune Therapeutics annual operating profit margin?
The current annual operating margin of ADAP is -228.99%
What is the all time high annual operating margin for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual operating profit margin is 13.49%
What is Adaptimmune Therapeutics annual operating margin year-on-year change?
Over the past year, ADAP annual operating profit margin has changed by +366.52% (+61.55%)
What is Adaptimmune Therapeutics quarterly operating profit margin?
The current quarterly operating margin of ADAP is -35.89%
What is the all time high quarterly operating margin for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly operating profit margin is 53.58%
What is Adaptimmune Therapeutics quarterly operating margin year-on-year change?
Over the past year, ADAP quarterly operating profit margin has changed by +601.26% (+94.37%)